The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Revascularization versus Medical Therapy for Renal-Artery Stenosis
Open accessAbstract
BACKGROUND: Percutaneous revascularization of the renal arteries improves patency in atherosclerotic renovascular disease, yet evidence of a clinical benefit is limited. METHODS: In a randomized, unblinded trial, we assigned 806 patients with atherosclerotic renovascular disease either to undergo revascularization in addition to receiving medical therapy or to receive medical therapy alone. The primary outcome was renal function, as measured by the reciprocal of the serum creatinine level (a measure that has a linear relationship with creatinine clearance). Secondary outcomes were blood pressure, the time to renal and major cardiovascular events, and mortality. The median follow-up was 34 months. RESULTS: During a 5-year period, the rate of progression of renal impairment (as shown by the slope of the reciprocal of the serum creatinine level) was -0.07x10(-3) liters per micromole per year in the revascularization group, as compared with -0.13x10(-3) liters per micromole per year in the medical-therapy group, a difference favoring revascularization of 0.06x10(-3) liters per micromole per year (95% confidence interval [CI], -0.002 to 0.13; P=0.06). Over the same time, the mean serum creatinine level was 1.6 micromol per liter (95% CI, -8.4 to 5.2 [0.02 mg per deciliter; 95% CI, -0.10 to 0.06]) lower in the revascularization group than in the medical-therapy group. There was no significant between-group difference in systolic blood pressure; the decrease in diastolic blood pressure was smaller in the revascularization group than in the medical-therapy group. The two study groups had similar rates of renal events (hazard ratio in the revascularization group, 0.97; 95% CI, 0.67 to 1.40; P=0.88), major cardiovascular events (hazard ratio, 0.94; 95% CI, 0.75 to 1.19; P=0.61), and death (hazard ratio, 0.90; 95% CI, 0.69 to 1.18; P=0.46). Serious complications associated with revascularization occurred in 23 patients, including 2 deaths and 3 amputations of toes or limbs. CONCLUSIONS: We found substantial risks but no evidence of a worthwhile clinical benefit from revascularization in patients with atherosclerotic renovascular disease. (Current Controlled Trials number, ISRCTN59586944.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Analysis of serial measurements in medical research.
Matthews, J. N., Altman, D. G., Campbell, M. J., & Royston, P. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,136
The Effect of Balloon Angioplasty on Hypertension in Atherosclerotic Renal-Artery Stenosis
van Jaarsveld, B. C., Krijnen, P., Pieterman, H., Derkx, F. H. M., Deinum, J., Postma, C. T., Dees, A., Woittiez, A. J. J., Bartelink, A. K. M., Man in `t Veld, A. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004063421403 · Cited by 897
Blood Pressure Outcome of Angioplasty in Atherosclerotic Renal Artery Stenosis: A Randomized Trial
Plouin, P.-F., Chatellier, G., Darné, B., & Raynaud, A. (1998) · Hypertension · doi:10.1161/01.hyp.31.3.823 · Cited by 585
Webster, J., Marshall, F., Abdalla, M., Dominiczak, A., Edwards, R., Isles, C., Loose, H., Main, J., Padfield, P., Russell, I., et al. (1998) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000599 · Cited by 538
Stent Placement for Renal Arterial Stenosis: Where Do We Stand? A Meta-analysis
Leertouwer, T. C., Gussenhoven, E. J., Bosch, J. L., van Jaarsveld, B. C., van Dijk, L. C., Deinum, J., & Man in 't Veld, A. J. (2000) · Radiology · doi:10.1148/radiology.216.1.r00jl0778 · Cited by 395
Effect of renal-artery stenting on progression of renovascular renal failure
Harden, P., MacLeod, M., Rodger, R., Baxter, G., Connell, J., Dominiczak, A., Junor, B., Briggs, J., & Moss, J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10093-3 · Cited by 367
Effect of Renal-Artery Stenting on Progression of Renovascular Renal Failure
Harden, P. N., MacLeod, M. J., Rodger, R. S. C., Baxter, G. M., Connell, J. M. C., Dominiczak, A. F., Junor, B. J. R., Brigs, J. D., & Moss, J. G. (1999) · The Journal of Urology · doi:10.1097/00005392-199903000-00090 · Cited by 356
Kalra, P. A., Guo, H., Kausz, A. T., Gilbertson, D. T., Liu, J., Chen, S.-C., Ishani, A., Collins, A. J., & Foley, R. N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00406.x · Cited by 334
Pickering, T., Devereux, R., James, G., Silane, M., Herman, L., Sotelo, J., Sos, T., & Laragh, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92668-2 · Cited by 301
Renal Artery Angioplasty: Technical Results and Clinical Outcome in 320 Patients
Bonelli, F. S., McKusick, M. A., Textor, S. C., Kos, P. B., Stanson, A. W., Johnson, C. M., Sheedy, P. F., Welch, T. J., & Schirger, A. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.11.1041 · Cited by 206
Ives, N. J. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.2.298 · Cited by 150
Seasonal Variations in Clinical and Laboratory Variables among Chronic Hemodialysis Patients
Cheung, A. K., Yan, G., Greene, T., Daugirdas, J. T., Dwyer, J. T., Levin, N. W., Ornt, D. B., Schulman, G., & Eknoyan, G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000026611.07106.a7 · Cited by 114
Epidemiology of Renal Dysfunction and Patient Outcome in Atherosclerotic Renal Artery Occlusion
Cheung, C. M., Wright, J. R., Shurrab, A. E., Mamtora, H., Foley, R. N., O'Donoghue, D. J., Waldek, S., & Kalra, P. A. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131149 · Cited by 112
Revascularization in atherosclerotic renal artery disease
Textor, S. C. (1998) · Kidney International · doi:10.1038/ki.1998.37 · Cited by 97
Atherosclerotic Renovascular Disease in Older US Patients Starting Dialysis, 1996 to 2001
Guo, H., Kalra, P. A., Gilbertson, D. T., Liu, J., Chen, S., Collins, A. J., & Foley, R. N. (2006) · Circulation · doi:10.1161/circulationaha.106.637751 · Cited by 95
Dilemmas in the management of renal artery stenosis
Cheung, C. M., Hegarty, J., & Kalra, P. A. (2005) · British Medical Bulletin · doi:10.1093/bmb/ldh049 · Cited by 58
Large-scale randomized evidence: trials and overviews
Gray, R. G., Collins, R., Peto, R., & Wheatley, K. (2008) · CRC Press eBooks · doi:10.1201/b13550-64 · Cited by 41
Anuric acute renal failure and pulmonary oedema: A case for urgent action
Chrysochou, C., Sinha, S., Chalmers, N., Kalra, P. R., & Kalra, P. A. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.07.121 · Cited by 30
The heart in renovascular disease—An association demanding further investigation
Hegarty, J., Wright, J. R., Kalra, P. R., & Kalra, P. A. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.10.020 · Cited by 16
Research works printed but not linked: 1
- 10.1007/s00270-007-9211-6 · doi:10.1007/s00270-007-9211-6
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx095 · Cited by 3,293
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Metadata
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-11-12
- Volume
- 361
- Issue
- 20
- Pages
- 1953-1962
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1560486856
- Cited by
- 1,193
- References
- 20
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.